Enhancement of vincristine sensitivity in retinoblastoma through Janus kinase inhibition by ruxolitinib.
Article in Anti-Cancer Drugs (May 2024)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Article in Anti-Cancer Drugs (May 2024)
Article in Frontiers in Cellular Neuroscience (October 2023)
Article in Tumor Biology (January 2023)